Results 91 to 100 of about 132,338 (167)

Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment. [PDF]

Oncoimmunology
Höppner S, Werr L, Szilagyi B, Bartenhagen C, Hellmann AM, Rosswog C, Linden E, Primke G, Kahlert Y, Ibruli N, Hemstedt N, Lorenz W, Brägelmann J, Hölzel M, Fischer M.   +14 more
europepmc   +1 more source

Correction: Lutskovich et al. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. <i>Biomedicines</i> 2025, <i>13</i>, 2130. [PDF]

Biomedicines
Lutskovich DV, Meleshko AN, Stepanova VM, Dormeshkin DO, Rubtsov YP.   +4 more
europepmc   +1 more source

Deep Learning-Based Analysis of Gene Expression Data and Gene-Related Information in Pediatric Surgical Oncology: A Scoping Review. [PDF]

Cancer Med
Berhe S, Fuchs SE, Akalin A, van der Steeg AFW, Warmann SW, Buser MAD, Markel M.   +6 more
europepmc   +1 more source

Pediatric orbital masses from a tertiary pediatric oncology referral center: clinical characteristics and survival outcomes from a 20-year single-center experience. [PDF]

BMC Pediatr
Ertekin M, Temuroglu A, Aksoy GR.
europepmc   +1 more source

Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma. [PDF]

Hum Genomics
Liu S, Wang Z, Shen J, Li L, Lin Y.
europepmc   +1 more source

AI-Assisted Preoperative Diagnosis of Wilms Tumor. [PDF]

Life (Basel)
Akay MA, Tatar OC, Tatar E, Demirsoy U, Anık Y, Yıldız GE, Varlıklı O.   +6 more
europepmc   +1 more source

Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma. [PDF]

Mol Cancer Ther
Lindsay J, Gaither J, Groff D, Samanta M, Kaufman R, Grossmann L, Hartnett N, Kendsersky N, Mycek EA, Diskin SJ, Maris JM.   +10 more
europepmc   +1 more source

Homovanillic acid and vanillylmandelic acid as neuroblastoma biomarkers in children. [PDF]

Biochem Med (Zagreb)
Kavalakatt S, Ivica J.
europepmc   +1 more source